Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Cancer Chemotherapy and Pharmacology|July 26, 2020
Phase Ib study of FOLFOXIRI plus ramucirumab as first-line treatment for patients with metastatic colorectal cancerYosuke Kito, Hironaga Satake, Hiroya Taniguchi, et al.
Future Oncology (London, England)|March 25, 2021
An observational study on nutrition status in gastric cancer patients receiving ramucirumab plus taxane: BALAST studyTakuro Mizukami, Tempei Miyaji, Yukiya Narita, et al.
Journal of the National Cancer Institute|May 18, 2022
The Molecular Landscape of Pancreatobiliary Cancers for Novel Targeted Therapies From Real-World Genomic ProfilingKumiko Umemoto, Hiroyuki Yamamoto, Ritsuko Oikawa, et al.
World Journal of Gastrointestinal Oncology|November 30, 2020
Inferior mesenteric arteriovenous fistula during treatment with bevacizumab in colorectal cancer patient: A case reportAyako Doi, Hiroyuki Takeda, Kumiko Umemoto, et al.
Investigational New Drugs|August 6, 2022
Phase I study of envafolimab (KN035), a novel subcutaneous single-domain anti-PD-L1 monoclonal antibody, in Japanese patients with advanced solid tumorsToshio Shimizu, Takako Eguchi Nakajima, Noboru Yamamoto, et al.
Targeted Oncology|April 13, 2024
The Molecular Landscape of Gastric Cancers for Novel Targeted Therapies from Real-World Genomic ProfilingHiroyuki Yamamoto, Hiroyuki Arai, Ritsuko Oikawa, et al.
JCO Precision Oncology|August 8, 2024
Genomic Profiling of Small Intestine Cancers From a Real-World Data Set Identifies Subgroups With Actionable AlterationsHiroyuki Takeda, Hiroyuki Yamamoto, Ritsuko Oikawa, et al.
Molecular and Clinical Oncology|December 2, 2015
Predictability of antitumor efficacy of cetuximab plus irinotecan based on skin rash severity according to observation period in patients with metastatic colorectal cancer following failure of fluorouracil, irinotecan and oxaliplatinYoshiki Horie, Kentaro Yamazaki, Taro Funakoshi, et al.
Journal of Gastroenterology|May 23, 2026
Diagnostic performance of droplet digital PCR for KRAS mutation analysis in pancreatic cancer cytology specimensKumiko Umemoto, Kazunari Nakahara, Nobuyuki Ohike, et al.
BMC Cancer|December 16, 2022
Feasibility of edoxaban for asymptomatic cancer-associated thrombosis in Japanese patients with gastrointestinal cancer: ExCAVE studyMichio Nakamura, Atsushi Ishiguro, Masayoshi Dazai, et al.
Pageof 3